Systemic Aging & Blood Rejuvenation Lab

Microvascular Organ Network & Paracrine Contagion Live D3 Vascular Map

Intervention Protocol

Baseline SASP Load (IL-6/TNF-α) 185.4 pg/mL

Dose Intensity & Regimen

Target Organ Focus

Biomarker Telemetry & Endpoint Gaps

Circulating SASP Reduction

58.6 %

Simulated Epigenetic Age Shift

-4.2 yrs

Tissue Recovery Index

0.74 / 1.00

Evidentiary Rigor Level

Tier 3

Evidentiary Red Flag: Lacks randomized placebo-controlled clinical outcome endpoints. Surrogate methylation clocks (Horvath/GrimAge) often shift with transient hydration or inflammation without translating into preserved organ reserve or extended functional lifespan.

Evidentiary Matrix: Startup Pilot vs FDA RCT Gold Standard

Evaluation Criterion	Generation Lab / Pilot	Gold Standard RCT
Cohort Control	Single-Arm / Influencers	Double-Blind Placebo
Primary Endpoint	Surrogate DNAm Clocks	Hard Organ Failure / VO2 Max
Systemic SASP Validation	Blood Serum Multiplex	Multi-Tissue Biopsy Clearance
Placebo Effect Isolation	Uncontrolled / Open-Label	Pre-registered Mock Infusion